Loading...
Docoh

VistaGen Therapeutics (VTGN)

News

From Benzinga Pro
Stocks That Hit 52-Week Lows On Tuesday
24 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Tuesday, 540 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Monday
23 May 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Monday, 149 companies reached new 52-week lows.
VistaGen Therapeutics Highlights Regulatory Update For Its PH94B: 'FDA agreed that data from nonclinical and clinical studies of PH94B completed to date provide no signal of abuse potential'
5 May 22
Biotech, News, FDA, General
The FDA agreed that data from nonclinical and clinical studies of PH94B completed to date provide no signal of abuse potential The FDA also agreed that additional nonclinical studies are not necessary to evaluate the
VistaGen and AffaMed Complete Key Regulatory Submissions For PALISADE Global Phase 3 Clinical Trial For PH94B
12 Apr 22
Biotech, News, General
VistaGen Therapeutics, Inc. (NASDAQ:VTGN) (VistaGen) and AffaMed Therapeutics (AffaMed) today announced they have completed regulatory preparations to initiate PALISADE Global, a Phase 3 clinical trial to evaluate the
Stocks That Hit 52-Week Lows On Tuesday
15 Mar 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
During Tuesday's session, 454 stocks hit new 52-week lows.
Stocks That Hit 52-Week Lows On Monday
14 Mar 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Monday, 671 companies achieved new lows for the year.
Stocks That Hit 52-Week Lows On Monday
7 Mar 22
News, Options, Intraday Update, Markets, Movers, Trading Ideas
On Monday, 524 stocks hit new 52-week lows.